Soluble mesothelin-related peptides in the diagnosis of malignant pleural mesothelioma. Scherpereel A, Grigoriu B, Conti M, Gey T, Gregoire M, Copin MC, Devos P, Chahine B, Porte H, & Lassalle P Am. J. Respir. Crit. Care Med., 173:1155-1160, 2006.
Soluble mesothelin-related peptides in the diagnosis of malignant pleural mesothelioma [link]Paper  doi  bibtex   
@article{scherpereel_a_SOLUBLE_2006,
title = {Soluble mesothelin-related peptides in the diagnosis of malignant pleural mesothelioma},
volume = {173},
issn = {1073-449X},
url = {http://www.ncbi.nlm.nih.gov/pubmed/16456138},
DOI = {10.1164/rccm.200511-1789OC},
Language = {English},
Journal = {Am. J. Respir. Crit. Care Med.},
author = {{Scherpereel A} and {Grigoriu B} and {Conti M} and {Gey T} and {Gregoire M} and {Copin MC} and {Devos P} and {Chahine B} and {Porte H} and {Lassalle P}},
year = {2006},
keywords = {Aged, Analysis of Variance, Area Under Curve, Asbestosis/metabolism, Asbestosis/mortality, Asbestosis/pathology*, Biomarkers, Tumor/analysis, Diagnosis, Differential, Disease Progression, Female, GPI-Linked Proteins, Humans, Male, Membrane Glycoproteins/analysis, Membrane Glycoproteins/metabolism*, Mesothelioma/blood, Mesothelioma/mortality, Mesothelioma/pathology*, Middle Aged, Neoplasm Staging, Osteopontin, Pleural Effusion, Malignant/diagnosis*, Pleural Effusion, Malignant/metabolism, Pleural Effusion, Malignant/mortality, Pleural Neoplasms/blood, Pleural Neoplasms/mortality, Pleural Neoplasms/pathology*, Prognosis, Prospective Studies, Sensitivity and Specificity, Sialoglycoproteins/metabolism*, Solubility, Survival Analysis},
pages = {1155-1160}
}

Downloads: 0